SlideShare una empresa de Scribd logo
1 de 60
Descargar para leer sin conexión
Management of Acute
Pancreatitis
2013 update
by
Ahmed Adel Abdelhakeem
Assistant lecturer
Internal Medicine Department - GIT unit
Asyut university hospital
Etiology
Etiology (most common)
** GALLSTONES (40 – 70 % )

usually an acute event and resolves when the stone is

removed or passes spontaneously.
** ALCOHOL (25 – 35 % )
- often manifests as a spectrum ranging from discrete

episodes of AP to chronic irreversible silent changes.
- the e diagnosis should not be entertained unless a
person has a history of over 5 years of heavy alcohol
consumption ( > 50 g per day )
Etiology ( other causes )
**PRIMARY AND SECONDARY HYPERTRIGLYCERIDEMIA can cause
AP however, these account for only 1 – 4 % of cases ( 36 ). Serum
triglycerides should rise above 1,000 mg / dl to be considered the
cause of AP (should be re-evaluated 1 month after discharge )
**HYPERCALCEMIA
**HYPERPARATHYROIDISM
**DRUGS o(6-mercaptopurine, azathioprine )
**BENIGN OR MALIGNANT mass that obstructs the main pancreatic
duct can result in AP. It has been estimated that 5 – 14 % of patients
with benign or malignant pancreatobiliary tumors present with
apparent IAP .Historically, adenocarcinoma of the pancreas was
considered a disease of old age. However, increasingly patients in
their 40s — and occasionally younger — are presenting with
pancreatic cancer.
This entity should be suspected in any patient > 40 years of age
with idiopathic pancreatitis.
Etiology ( IDIOPATHIC AP )
** IAP is defined as pancreatitis with no etiology established
after initial laboratory (including lipid and calcium level) and
imaging tests ( transabdominal U/S and CT in the appropriate
patient).
** Anatomic anomalies of the pancreas occur in 10 – 15 % of
the population, including pancreas divisum and sphincter of
oddi dysfunction
** The role of Genetic testing in AP has yet to be determined
, but may be useful in patients with:
- young patients ( < 30 years old )
- no cause is evident
- family history of pancreatic disease is present
DIAGNOSIS
- CLINICAL PRESENTATION

- LABORATORY PARAMETERS
- ABDOMINAL IMAGING
DIAGNOSIS
The diagnosis of AP is most often established by the
presence of 2 of the 3 following criteria:
(1) abdominal pain consistent with the disease,
(2) serum amylase and / or lipase greater than three
times the upper limit of normal, and / or
(3) characteristic findings from abdominal imaging.
Contrast-enhanced computed tomography (CECT) and / or
magnetic resonance imaging (MRI) of the pancreas should
be reserved for patients in whom the diagnosis is unclear
DIAGNOSIS (Clinical Presentation)
** Patients with AP typically present with epigastric or left
upper quadrant pain.

** The pain is usually described as constant with radiation to
the back, chest, or flanks but this description is nonspecific.
** The intensity of the pain is usually severe, but can be
variable. the intensity and location of the pain do not
correlate with severity. Pain described as dull, colicky, or
located in the lower abdominal region is not consistent with
AP and suggests an alternative etiology.
DIAGNOSIS ( Serum Amylase )
** cannot be used reliably for the diagnosis of AP.

** rises within a few hours after the onset of symptoms and
returns to normal values within 3 – 5 days; however, it may
remain within the normal range on admission in as many as
one-fifth of patients.
** most studies show a diagnostic efficacy of greater than
3 – 5 times the upper limit of normal
DIAGNOSIS ( Serum Amylase )
may be normal in:
*Alcohol-induced AP

*Hypertriglyceridemia.

Serum amylase concentrations might be high in the
absence of AP in:
*Macroamylasaemia *

glomerular filtration rate

*Diseases of the salivary glands
*Extra pancreatic abdominal diseases associated with

inflammation including : acute appendicitis, cholecystitis,
intestinal obstruction or ischemia, peptic ulcer, and
gynecological diseases.
DIAGNOSIS ( Serum Lipase )
** more specific
** remains elevated longer than amylase after disease
presentation
** similar problems with the predictive value remain in
certain patient populations , including :
- Macro lipasemia
- Renal disease , appendicitis , cholecystitis

- Diabetics who appear to have higher median lipase ( 3 – 5
times may be needed )
DIAGNOSIS ( Serum Lipase )
Neither serum amylase nor lipase
has any role in prognosis , assessing

severity or follow up.
DIAGNOSIS (Abdominal Imaging)
Abdominal U/S :
- Transabdominal ultrasound should be performed in
all patients with AP.
CECT: Routine use of CECT in patients with AP is

unwarranted , as the diagnosis is apparent in many
patients and most have a mild , uncomplicated
course.
DIAGNOSIS (Abdominal Imaging)
- Indications of CECT :
- Patient failing to improve after 48 – 72 hr after
admission ( persistent pain , fever , nausea, unable to
begin oral feeding ).

- Uncertain diagnosis
- Patient > 40 years old ( pancreatic tumor should be
considered as a possible cause ).
DIAGNOSIS (ABDOMINAL IMAGING)
MRI : helpful in patients with a contrast allergy and renal
insufficiency where T2-weighted images without

gadolinium contrast can diagnose pancreatic necrosis

MRCP: has the advantage of detecting
choledocholithiasis down to 3 mm diameter and
pancreatic duct disruption if CT is non - conclusive.

EUS : used when a more extensive evaluation for a
suspected underlying pathology is needed after a recurrent
episode of IAP
DIAGNOSIS ( Role of ERCP )
- Patients with AP and concurrent acute cholangitis should
undergo ERCP within 24 h of admission

- ERCP is not needed early in most patients with gallstone
pancreatitis who lack laboratory or clinical evidence of ongoing biliary
obstruction
- In the absence of cholangitis and / or jaundice, MRCP or EUS rather
than diagnostic ERCP should be used to screen for choledocholithiasis
if highly suspected.
- Pancreatic duct stents and / or post procedure rectal nonsteroidal
anti-inflammatory drug (NSAID) suppositories ( indomethacin rectal
supp. 100 mg once post procedure ) should be utilized to lower the
risk of severe post-ERCP pancreatitis in high-risk patients.
Assessment of severity
Atlanta Revised criteria 2013
Based on : local complications and presence of
organ failure.

BISAP score
Ranson’s criteria
Assessment of severity
Atlanta Revised criteria 2013
Mild acute pancreatitis
Absence of organ failure
Absence of local complications
Moderately severe acute pancreatitis

Local complications AND / OR
Transient organ failure ( < 48 h)
exacerbated co - morbidities

Severe acute pancreatitis (15 – 20 %)
Persistent organ failure > 48 h
Assessment of severity
- Local complications include : peripancreatic fluid collections and
pancreatic or peripancreatic necrosis (sterile or infected)
- Pancreatic necrosis is defined as diffuse or focal areas of nonviable

pancreatic parenchyma > 3 cm in size or > 30% of the pancreas
- edematous pancreas is defined as interstitial pancreatitis
- CT and / or MRI imaging also cannot reliably determine
severity early in the course of AP, as necrosis usually is not present
on admission and may develop after 24 – 48 h
- different scoring systems are available for assessing severity but
all of them are cumbersome and typically require 48 h to become

accurate.
Assessment of severity
Organ failure :
Assessment of severity
BISAP score
Assessment of severity
Ranson’s criteria:
Acute pancreatitis 2013 update
Acute pancreatitis 2013 update
Assessment of severity
Mild disease

Severe disease

- Mild pain
- Normal look
- Normal pulse rate
- Normal temp. or mild fever

- Severe pain
- Toxic look
- Tachycardia
- High grade or subnormal
temp.
- Hypoxia
- Decreased UOP
- Rigid abdomen
- shock

- Normal O2 saturation
- Adequate UOP
- Flat soft abdomen
- Normal BP
Assessment of severity
Mild disease

Severe disease

- Mild pain
- Normal look
- Normal pulse rate
- Normal temp. or mild fever

- Severe pain
- Toxic look
- Tachycardia
- High grade or subnormal
temp.
- Hypoxia
- Decreased UOP
- Rigid abdomen
- shock

- Normal O2 saturation
- Adequate UOP
- Flat soft abdomen
- Normal BP
Assessment of severity
- Most patients with severe disease present to the emergency room
with no organ failure or pancreatic necrosis; unfortunately, this has
led to many errors in clinical management of this disease.
- These errors include failure to provide adequate hydration, failure
to diagnose and treat cholangitis, and failure to treat early organ
failure.
- For this reason, it is critical for the clinician to recognize the
importance of not falsely labeling a patient with mild disease within
the first 48 h of admission for AP.
Assessment of severity
If there is

:

- 100 cases of AP

>>>>>

20 cases will be

severe ( 20 % ) .
- from those 20 cases
be infected ( 4 % ) .

>>>>>

4 cases will
Management
- Aggressive hydration
- Antibiotics
- Nutrition
- Role of ERCP

- Role of surgery
Management (Aggressive hydration)
Management (Aggressive hydration)
-- The use of hematocrit , BUN and creatinine as
surrogate markers for successful hydration has been
widely recommended.
-- Although no firm recommendations regarding
absolute numbers can be made at this time, the goal to

decrease hematocrit ( demonstrating hemodilution ) and
BUN ( increasing renal perfusion ) and maintain a normal
creatinine during the first day of hospitalization is

recommended.
Management (Antibiotics)
Management (Antibiotics)
- Fever, tachycardia, tachypnea, and leukocytosis associated
with SIRS that may occur early in the course of AP may be
indistinguishable from sepsis syndrome.
- When an infection is suspected, antibiotics should be given
while the source of the infection is being investigated.

- However, once blood and other cultures are found to be
negative and no source of infection is identified, antibiotics
should be discontinued
Management (Role of CT FNA)
Management (Role of Surgery)
Management (Role of Surgery)
cholecystectomy:
*Mild gallstone pancreatitis: should be performed during
hospitalization
*Severe AP: cholecystectomy is typically delayed after
discharge except if necrosectomy will be done.
*No stones / sludge on ultrasound and recurrent pancreatitis :
no role for cholecystectomy.
*In patients with mild AP who cannot undergo surgery, such
as the frail elderly and / or those with severe co morbid
disease, biliary sphincterotomy alone may be an effective way
to reduce further attacks of AP, although attacks of
cholecystitis may still occur
Management (Role of Surgery)
Necrosectomy (debridement):
- Early open debridement for sterile necrosis was
abandoned
- Debridement for sterile necrosis is recommended
if associated with:
*Gastric outlet obstruction and / or
*Bile duct obstruction.
Management (Role of Surgery)
Minimally invasive Necrosectomy :
Debridement through :
- Laparoscopic ,
- Percutaneous or
- Radiologic
by catheter drain
** Becoming the standard of care for cases of severe
necrotizing pancreatitis requiring debridement.
Management (Nutrition)
Management (Role of ERCP)
Management (Role of ERCP)
PREVENTING POST-ERCP PANCREATITIS (2 – 4
%) :
(1) Guide wire cannulation,
(2) pancreatic duct stents
(3) rectal NSAIDs ( Diclofenac 100 mg or
Indomethacin 100 mg once post procedure )
Acute pancreatitis 2013 update
Acute pancreatitis 2013 update
Systemic Complications of AP
Local Complications of AP
Pancreatic pseudo cyst
Pancreatic abscess
Necrotizing pancreatitis
Hemorrhagic pancreatitis
Pseudo -Cyst
- Localized fluid collection that is rich in amylase and other
pancreatic enzymes and is surrounded by a wall of fibrous tissue
that is not lined by epithelium.
- May remain within pancreatic parenchyma , extend into lesser
sac or retro peritoneum.
- Common clinical problem and complicate the course of chronic
pancreatitis in 30% to 40% of patients
Pseudo –Cyst …
Presentation
- Asymptomatic
- Acute complications include : bleeding (usually from splenic
artery pseudoaneurysm), infection, and rupture

- Chronic complications include gastric outlet obstruction,
biliary obstruction and thrombosis of the splenic or portal vein
with development of Gastric Varices secondary to portal
hypertension.
Pseudo -Cyst
Differential Diagnosis
- Once pancreatic cyst is identified by an imaging modality, the
most important question is to differentiate pseudo cyst from
other TRUE cystic lesions of the pancreas.
- The main differentiating features are :
1 - History of acute pancreatitis.
2 – amylase level ( very high in pseudo cyst )
3 – Aspiration of cyst content ( CEA , amylase , bacteriology ,
cytology ) usually and preferably done by EUS.
Pseudo -Cyst
Treatment
Wait 6 weeks post AP .. Why ?
Some pseudo cysts disappear spontaneously within 6 weeks.
To give sufficient time for a thick pseudo capsule to form.
Options :
- Endoscopic : cystogastrostomy.
- Percutaneous : pig – tail drainage.
Acute pancreatitis 2013 update
Acute pancreatitis 2013 update
Pancreatic Abscess
- Occurs as a complication of pseudo cyst if not drained.
- Complicates about 4 % of cases.
- The only reliable sign in CT is the presence of air bubbles within
the cyst that arises mainly from gas forming organism or a
fistula with the stomach, but unfortunately this is present only
in 50 % of cases.
- Diagnostic aspiration may differentiate it from a pseudo cyst if
there is no air bubbles ( physical , bacteriology , cells ).
- It was an indication for surgery in the past but now it could be
drained percutaneously (pig tail).
Acute pancreatitis 2013 update
Acute pancreatitis 2013 update
Acute pancreatitis 2013 update
Acute pancreatitis 2013 update
Acute pancreatitis 2013 update
Acute pancreatitis 2013 update
Acute pancreatitis 2013 update
Thank you

Más contenido relacionado

La actualidad más candente

Acute pancreatitis final
Acute pancreatitis finalAcute pancreatitis final
Acute pancreatitis finalIndhu Reddy
 
22 acute pancreatitis
22 acute pancreatitis22 acute pancreatitis
22 acute pancreatitisinternalmed
 
Obstructive jaundice 19_9_2014
Obstructive jaundice 19_9_2014Obstructive jaundice 19_9_2014
Obstructive jaundice 19_9_2014DrAnum Ammad
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitisRahul Garg
 
Management of acute pancreatitis
Management of acute pancreatitisManagement of acute pancreatitis
Management of acute pancreatitisSubhasish Deb
 
Obstructive jaundice management
Obstructive jaundice managementObstructive jaundice management
Obstructive jaundice managementAhmed Almumtin
 
Acute pancreatitis atlanta classification & management
Acute pancreatitis   atlanta classification & managementAcute pancreatitis   atlanta classification & management
Acute pancreatitis atlanta classification & managementSeneeth Peramuna
 
Acute pancreatitis
Acute pancreatitis Acute pancreatitis
Acute pancreatitis Mohsin Khan
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitisitssuesaleh
 
Mesenteric ischemia
Mesenteric ischemiaMesenteric ischemia
Mesenteric ischemiaRawan Aljawi
 
Diverticulitis
DiverticulitisDiverticulitis
Diverticulitisshabeel pn
 
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®Gastrolearning
 
Cholangiocarcinoma ppt
Cholangiocarcinoma pptCholangiocarcinoma ppt
Cholangiocarcinoma ppthafeezyaqoob
 

La actualidad más candente (20)

Acute pancreatitis final
Acute pancreatitis finalAcute pancreatitis final
Acute pancreatitis final
 
22 acute pancreatitis
22 acute pancreatitis22 acute pancreatitis
22 acute pancreatitis
 
Obstructive jaundice 19_9_2014
Obstructive jaundice 19_9_2014Obstructive jaundice 19_9_2014
Obstructive jaundice 19_9_2014
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Management of acute pancreatitis
Management of acute pancreatitisManagement of acute pancreatitis
Management of acute pancreatitis
 
Obstructive jaundice management
Obstructive jaundice managementObstructive jaundice management
Obstructive jaundice management
 
Acute pancreatitis atlanta classification & management
Acute pancreatitis   atlanta classification & managementAcute pancreatitis   atlanta classification & management
Acute pancreatitis atlanta classification & management
 
UGI Bleed
UGI BleedUGI Bleed
UGI Bleed
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Acute pancreatitis
Acute pancreatitis Acute pancreatitis
Acute pancreatitis
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Mesenteric ischemia
Mesenteric ischemiaMesenteric ischemia
Mesenteric ischemia
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Gastritis
GastritisGastritis
Gastritis
 
Pancreatitis
PancreatitisPancreatitis
Pancreatitis
 
Diverticulitis
DiverticulitisDiverticulitis
Diverticulitis
 
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
Il trattamento chirurgico del colangiocarcinoma - Gastrolearning®
 
Cholangiocarcinoma ppt
Cholangiocarcinoma pptCholangiocarcinoma ppt
Cholangiocarcinoma ppt
 
Liver trauma
Liver traumaLiver trauma
Liver trauma
 

Destacado

Acute Pancreatitis (According to American College of Gastroenterology 2013 gu...
Acute Pancreatitis (According to American College of Gastroenterology 2013 gu...Acute Pancreatitis (According to American College of Gastroenterology 2013 gu...
Acute Pancreatitis (According to American College of Gastroenterology 2013 gu...Jibran Mohsin
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitisAtit Ghoda
 
Acute and Chronic Pancreatitis
Acute and Chronic PancreatitisAcute and Chronic Pancreatitis
Acute and Chronic Pancreatitismarcosmachado
 
Revised Atlanta classification of Acute Pancreatitis
Revised Atlanta classification of Acute PancreatitisRevised Atlanta classification of Acute Pancreatitis
Revised Atlanta classification of Acute PancreatitisDr M Venkatesh
 
Update of atlanta classification of acute pancreatitis published
Update of atlanta classification of acute pancreatitis publishedUpdate of atlanta classification of acute pancreatitis published
Update of atlanta classification of acute pancreatitis publishedDr Priyanka Vishwakarma
 
Evidence Based Treatment of Acute Pancreatitis 2013
Evidence Based Treatment of Acute Pancreatitis 2013Evidence Based Treatment of Acute Pancreatitis 2013
Evidence Based Treatment of Acute Pancreatitis 2013Waleed Mahrous
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitisatul gawande
 
Acute pancreatitis.ppt
Acute pancreatitis.pptAcute pancreatitis.ppt
Acute pancreatitis.pptIbrahim Odeh
 
Acute Pancreatitis
Acute PancreatitisAcute Pancreatitis
Acute PancreatitisSimmedic UKM
 
Pancreatitis by manjusb
Pancreatitis by manjusbPancreatitis by manjusb
Pancreatitis by manjusbmanjusb61
 

Destacado (11)

Acute Pancreatitis (According to American College of Gastroenterology 2013 gu...
Acute Pancreatitis (According to American College of Gastroenterology 2013 gu...Acute Pancreatitis (According to American College of Gastroenterology 2013 gu...
Acute Pancreatitis (According to American College of Gastroenterology 2013 gu...
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Acute and Chronic Pancreatitis
Acute and Chronic PancreatitisAcute and Chronic Pancreatitis
Acute and Chronic Pancreatitis
 
Pancreatitis
PancreatitisPancreatitis
Pancreatitis
 
Revised Atlanta classification of Acute Pancreatitis
Revised Atlanta classification of Acute PancreatitisRevised Atlanta classification of Acute Pancreatitis
Revised Atlanta classification of Acute Pancreatitis
 
Update of atlanta classification of acute pancreatitis published
Update of atlanta classification of acute pancreatitis publishedUpdate of atlanta classification of acute pancreatitis published
Update of atlanta classification of acute pancreatitis published
 
Evidence Based Treatment of Acute Pancreatitis 2013
Evidence Based Treatment of Acute Pancreatitis 2013Evidence Based Treatment of Acute Pancreatitis 2013
Evidence Based Treatment of Acute Pancreatitis 2013
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Acute pancreatitis.ppt
Acute pancreatitis.pptAcute pancreatitis.ppt
Acute pancreatitis.ppt
 
Acute Pancreatitis
Acute PancreatitisAcute Pancreatitis
Acute Pancreatitis
 
Pancreatitis by manjusb
Pancreatitis by manjusbPancreatitis by manjusb
Pancreatitis by manjusb
 

Similar a Acute pancreatitis 2013 update

Similar a Acute pancreatitis 2013 update (20)

Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
pancreatitis
pancreatitispancreatitis
pancreatitis
 
Git j club ap16.
Git j club ap16.Git j club ap16.
Git j club ap16.
 
Approach-to-Patients-with-Pancreatic-Diseases-pdf.pdf
Approach-to-Patients-with-Pancreatic-Diseases-pdf.pdfApproach-to-Patients-with-Pancreatic-Diseases-pdf.pdf
Approach-to-Patients-with-Pancreatic-Diseases-pdf.pdf
 
Dr. Amit Annand Acute Pancreatitis.pptx
Dr. Amit Annand Acute Pancreatitis.pptxDr. Amit Annand Acute Pancreatitis.pptx
Dr. Amit Annand Acute Pancreatitis.pptx
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
acute pancreatitis.pptx
acute pancreatitis.pptxacute pancreatitis.pptx
acute pancreatitis.pptx
 
Acute pancreatitis
Acute pancreatitis Acute pancreatitis
Acute pancreatitis
 
Pancreatitis
PancreatitisPancreatitis
Pancreatitis
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Acute Pancreatitis.pptx
Acute Pancreatitis.pptxAcute Pancreatitis.pptx
Acute Pancreatitis.pptx
 
Pancreatitis .pptx
Pancreatitis .pptxPancreatitis .pptx
Pancreatitis .pptx
 
Acute pancreatitis 2015
Acute pancreatitis   2015Acute pancreatitis   2015
Acute pancreatitis 2015
 
PANCREAS.pptx
PANCREAS.pptxPANCREAS.pptx
PANCREAS.pptx
 
pancreas.pptx
pancreas.pptxpancreas.pptx
pancreas.pptx
 
Pancreatitis
PancreatitisPancreatitis
Pancreatitis
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Pancreatitis - etiology, pathophysiology and nutrition
Pancreatitis - etiology, pathophysiology and nutritionPancreatitis - etiology, pathophysiology and nutrition
Pancreatitis - etiology, pathophysiology and nutrition
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 

Más de Ahmed Adel

Abnormal liver function tests
Abnormal liver function testsAbnormal liver function tests
Abnormal liver function testsAhmed Adel
 
Management of Cirrhotic Ascites and its Related Complications
Management of Cirrhotic Ascites and its Related ComplicationsManagement of Cirrhotic Ascites and its Related Complications
Management of Cirrhotic Ascites and its Related ComplicationsAhmed Adel
 
Clinical Cases in Gastroenterology and Hepatology
Clinical Cases in Gastroenterology and HepatologyClinical Cases in Gastroenterology and Hepatology
Clinical Cases in Gastroenterology and HepatologyAhmed Adel
 
Cholestatic liver diseases in adults
Cholestatic liver diseases in adultsCholestatic liver diseases in adults
Cholestatic liver diseases in adultsAhmed Adel
 
Preoperative Evaluation For Living Donor Liver Transplantation
Preoperative Evaluation For Living Donor Liver TransplantationPreoperative Evaluation For Living Donor Liver Transplantation
Preoperative Evaluation For Living Donor Liver TransplantationAhmed Adel
 
Indicatins of salt free albumin
Indicatins of salt free albuminIndicatins of salt free albumin
Indicatins of salt free albuminAhmed Adel
 
Road To International Medical studentship
Road To International Medical studentshipRoad To International Medical studentship
Road To International Medical studentshipAhmed Adel
 

Más de Ahmed Adel (7)

Abnormal liver function tests
Abnormal liver function testsAbnormal liver function tests
Abnormal liver function tests
 
Management of Cirrhotic Ascites and its Related Complications
Management of Cirrhotic Ascites and its Related ComplicationsManagement of Cirrhotic Ascites and its Related Complications
Management of Cirrhotic Ascites and its Related Complications
 
Clinical Cases in Gastroenterology and Hepatology
Clinical Cases in Gastroenterology and HepatologyClinical Cases in Gastroenterology and Hepatology
Clinical Cases in Gastroenterology and Hepatology
 
Cholestatic liver diseases in adults
Cholestatic liver diseases in adultsCholestatic liver diseases in adults
Cholestatic liver diseases in adults
 
Preoperative Evaluation For Living Donor Liver Transplantation
Preoperative Evaluation For Living Donor Liver TransplantationPreoperative Evaluation For Living Donor Liver Transplantation
Preoperative Evaluation For Living Donor Liver Transplantation
 
Indicatins of salt free albumin
Indicatins of salt free albuminIndicatins of salt free albumin
Indicatins of salt free albumin
 
Road To International Medical studentship
Road To International Medical studentshipRoad To International Medical studentship
Road To International Medical studentship
 

Último

Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 

Último (20)

Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 

Acute pancreatitis 2013 update

  • 1. Management of Acute Pancreatitis 2013 update by Ahmed Adel Abdelhakeem Assistant lecturer Internal Medicine Department - GIT unit Asyut university hospital
  • 3. Etiology (most common) ** GALLSTONES (40 – 70 % ) usually an acute event and resolves when the stone is removed or passes spontaneously. ** ALCOHOL (25 – 35 % ) - often manifests as a spectrum ranging from discrete episodes of AP to chronic irreversible silent changes. - the e diagnosis should not be entertained unless a person has a history of over 5 years of heavy alcohol consumption ( > 50 g per day )
  • 4. Etiology ( other causes ) **PRIMARY AND SECONDARY HYPERTRIGLYCERIDEMIA can cause AP however, these account for only 1 – 4 % of cases ( 36 ). Serum triglycerides should rise above 1,000 mg / dl to be considered the cause of AP (should be re-evaluated 1 month after discharge ) **HYPERCALCEMIA **HYPERPARATHYROIDISM **DRUGS o(6-mercaptopurine, azathioprine ) **BENIGN OR MALIGNANT mass that obstructs the main pancreatic duct can result in AP. It has been estimated that 5 – 14 % of patients with benign or malignant pancreatobiliary tumors present with apparent IAP .Historically, adenocarcinoma of the pancreas was considered a disease of old age. However, increasingly patients in their 40s — and occasionally younger — are presenting with pancreatic cancer. This entity should be suspected in any patient > 40 years of age with idiopathic pancreatitis.
  • 5. Etiology ( IDIOPATHIC AP ) ** IAP is defined as pancreatitis with no etiology established after initial laboratory (including lipid and calcium level) and imaging tests ( transabdominal U/S and CT in the appropriate patient). ** Anatomic anomalies of the pancreas occur in 10 – 15 % of the population, including pancreas divisum and sphincter of oddi dysfunction ** The role of Genetic testing in AP has yet to be determined , but may be useful in patients with: - young patients ( < 30 years old ) - no cause is evident - family history of pancreatic disease is present
  • 6. DIAGNOSIS - CLINICAL PRESENTATION - LABORATORY PARAMETERS - ABDOMINAL IMAGING
  • 7. DIAGNOSIS The diagnosis of AP is most often established by the presence of 2 of the 3 following criteria: (1) abdominal pain consistent with the disease, (2) serum amylase and / or lipase greater than three times the upper limit of normal, and / or (3) characteristic findings from abdominal imaging. Contrast-enhanced computed tomography (CECT) and / or magnetic resonance imaging (MRI) of the pancreas should be reserved for patients in whom the diagnosis is unclear
  • 8. DIAGNOSIS (Clinical Presentation) ** Patients with AP typically present with epigastric or left upper quadrant pain. ** The pain is usually described as constant with radiation to the back, chest, or flanks but this description is nonspecific. ** The intensity of the pain is usually severe, but can be variable. the intensity and location of the pain do not correlate with severity. Pain described as dull, colicky, or located in the lower abdominal region is not consistent with AP and suggests an alternative etiology.
  • 9. DIAGNOSIS ( Serum Amylase ) ** cannot be used reliably for the diagnosis of AP. ** rises within a few hours after the onset of symptoms and returns to normal values within 3 – 5 days; however, it may remain within the normal range on admission in as many as one-fifth of patients. ** most studies show a diagnostic efficacy of greater than 3 – 5 times the upper limit of normal
  • 10. DIAGNOSIS ( Serum Amylase ) may be normal in: *Alcohol-induced AP *Hypertriglyceridemia. Serum amylase concentrations might be high in the absence of AP in: *Macroamylasaemia * glomerular filtration rate *Diseases of the salivary glands *Extra pancreatic abdominal diseases associated with inflammation including : acute appendicitis, cholecystitis, intestinal obstruction or ischemia, peptic ulcer, and gynecological diseases.
  • 11. DIAGNOSIS ( Serum Lipase ) ** more specific ** remains elevated longer than amylase after disease presentation ** similar problems with the predictive value remain in certain patient populations , including : - Macro lipasemia - Renal disease , appendicitis , cholecystitis - Diabetics who appear to have higher median lipase ( 3 – 5 times may be needed )
  • 12. DIAGNOSIS ( Serum Lipase ) Neither serum amylase nor lipase has any role in prognosis , assessing severity or follow up.
  • 13. DIAGNOSIS (Abdominal Imaging) Abdominal U/S : - Transabdominal ultrasound should be performed in all patients with AP. CECT: Routine use of CECT in patients with AP is unwarranted , as the diagnosis is apparent in many patients and most have a mild , uncomplicated course.
  • 14. DIAGNOSIS (Abdominal Imaging) - Indications of CECT : - Patient failing to improve after 48 – 72 hr after admission ( persistent pain , fever , nausea, unable to begin oral feeding ). - Uncertain diagnosis - Patient > 40 years old ( pancreatic tumor should be considered as a possible cause ).
  • 15. DIAGNOSIS (ABDOMINAL IMAGING) MRI : helpful in patients with a contrast allergy and renal insufficiency where T2-weighted images without gadolinium contrast can diagnose pancreatic necrosis MRCP: has the advantage of detecting choledocholithiasis down to 3 mm diameter and pancreatic duct disruption if CT is non - conclusive. EUS : used when a more extensive evaluation for a suspected underlying pathology is needed after a recurrent episode of IAP
  • 16. DIAGNOSIS ( Role of ERCP ) - Patients with AP and concurrent acute cholangitis should undergo ERCP within 24 h of admission - ERCP is not needed early in most patients with gallstone pancreatitis who lack laboratory or clinical evidence of ongoing biliary obstruction - In the absence of cholangitis and / or jaundice, MRCP or EUS rather than diagnostic ERCP should be used to screen for choledocholithiasis if highly suspected. - Pancreatic duct stents and / or post procedure rectal nonsteroidal anti-inflammatory drug (NSAID) suppositories ( indomethacin rectal supp. 100 mg once post procedure ) should be utilized to lower the risk of severe post-ERCP pancreatitis in high-risk patients.
  • 17. Assessment of severity Atlanta Revised criteria 2013 Based on : local complications and presence of organ failure. BISAP score Ranson’s criteria
  • 18. Assessment of severity Atlanta Revised criteria 2013 Mild acute pancreatitis Absence of organ failure Absence of local complications Moderately severe acute pancreatitis Local complications AND / OR Transient organ failure ( < 48 h) exacerbated co - morbidities Severe acute pancreatitis (15 – 20 %) Persistent organ failure > 48 h
  • 19. Assessment of severity - Local complications include : peripancreatic fluid collections and pancreatic or peripancreatic necrosis (sterile or infected) - Pancreatic necrosis is defined as diffuse or focal areas of nonviable pancreatic parenchyma > 3 cm in size or > 30% of the pancreas - edematous pancreas is defined as interstitial pancreatitis - CT and / or MRI imaging also cannot reliably determine severity early in the course of AP, as necrosis usually is not present on admission and may develop after 24 – 48 h - different scoring systems are available for assessing severity but all of them are cumbersome and typically require 48 h to become accurate.
  • 25. Assessment of severity Mild disease Severe disease - Mild pain - Normal look - Normal pulse rate - Normal temp. or mild fever - Severe pain - Toxic look - Tachycardia - High grade or subnormal temp. - Hypoxia - Decreased UOP - Rigid abdomen - shock - Normal O2 saturation - Adequate UOP - Flat soft abdomen - Normal BP
  • 26. Assessment of severity Mild disease Severe disease - Mild pain - Normal look - Normal pulse rate - Normal temp. or mild fever - Severe pain - Toxic look - Tachycardia - High grade or subnormal temp. - Hypoxia - Decreased UOP - Rigid abdomen - shock - Normal O2 saturation - Adequate UOP - Flat soft abdomen - Normal BP
  • 27. Assessment of severity - Most patients with severe disease present to the emergency room with no organ failure or pancreatic necrosis; unfortunately, this has led to many errors in clinical management of this disease. - These errors include failure to provide adequate hydration, failure to diagnose and treat cholangitis, and failure to treat early organ failure. - For this reason, it is critical for the clinician to recognize the importance of not falsely labeling a patient with mild disease within the first 48 h of admission for AP.
  • 28. Assessment of severity If there is : - 100 cases of AP >>>>> 20 cases will be severe ( 20 % ) . - from those 20 cases be infected ( 4 % ) . >>>>> 4 cases will
  • 29. Management - Aggressive hydration - Antibiotics - Nutrition - Role of ERCP - Role of surgery
  • 31. Management (Aggressive hydration) -- The use of hematocrit , BUN and creatinine as surrogate markers for successful hydration has been widely recommended. -- Although no firm recommendations regarding absolute numbers can be made at this time, the goal to decrease hematocrit ( demonstrating hemodilution ) and BUN ( increasing renal perfusion ) and maintain a normal creatinine during the first day of hospitalization is recommended.
  • 33. Management (Antibiotics) - Fever, tachycardia, tachypnea, and leukocytosis associated with SIRS that may occur early in the course of AP may be indistinguishable from sepsis syndrome. - When an infection is suspected, antibiotics should be given while the source of the infection is being investigated. - However, once blood and other cultures are found to be negative and no source of infection is identified, antibiotics should be discontinued
  • 36. Management (Role of Surgery) cholecystectomy: *Mild gallstone pancreatitis: should be performed during hospitalization *Severe AP: cholecystectomy is typically delayed after discharge except if necrosectomy will be done. *No stones / sludge on ultrasound and recurrent pancreatitis : no role for cholecystectomy. *In patients with mild AP who cannot undergo surgery, such as the frail elderly and / or those with severe co morbid disease, biliary sphincterotomy alone may be an effective way to reduce further attacks of AP, although attacks of cholecystitis may still occur
  • 37. Management (Role of Surgery) Necrosectomy (debridement): - Early open debridement for sterile necrosis was abandoned - Debridement for sterile necrosis is recommended if associated with: *Gastric outlet obstruction and / or *Bile duct obstruction.
  • 38. Management (Role of Surgery) Minimally invasive Necrosectomy : Debridement through : - Laparoscopic , - Percutaneous or - Radiologic by catheter drain ** Becoming the standard of care for cases of severe necrotizing pancreatitis requiring debridement.
  • 41. Management (Role of ERCP) PREVENTING POST-ERCP PANCREATITIS (2 – 4 %) : (1) Guide wire cannulation, (2) pancreatic duct stents (3) rectal NSAIDs ( Diclofenac 100 mg or Indomethacin 100 mg once post procedure )
  • 45. Local Complications of AP Pancreatic pseudo cyst Pancreatic abscess Necrotizing pancreatitis Hemorrhagic pancreatitis
  • 46. Pseudo -Cyst - Localized fluid collection that is rich in amylase and other pancreatic enzymes and is surrounded by a wall of fibrous tissue that is not lined by epithelium. - May remain within pancreatic parenchyma , extend into lesser sac or retro peritoneum. - Common clinical problem and complicate the course of chronic pancreatitis in 30% to 40% of patients
  • 47. Pseudo –Cyst … Presentation - Asymptomatic - Acute complications include : bleeding (usually from splenic artery pseudoaneurysm), infection, and rupture - Chronic complications include gastric outlet obstruction, biliary obstruction and thrombosis of the splenic or portal vein with development of Gastric Varices secondary to portal hypertension.
  • 48. Pseudo -Cyst Differential Diagnosis - Once pancreatic cyst is identified by an imaging modality, the most important question is to differentiate pseudo cyst from other TRUE cystic lesions of the pancreas. - The main differentiating features are : 1 - History of acute pancreatitis. 2 – amylase level ( very high in pseudo cyst ) 3 – Aspiration of cyst content ( CEA , amylase , bacteriology , cytology ) usually and preferably done by EUS.
  • 49. Pseudo -Cyst Treatment Wait 6 weeks post AP .. Why ? Some pseudo cysts disappear spontaneously within 6 weeks. To give sufficient time for a thick pseudo capsule to form. Options : - Endoscopic : cystogastrostomy. - Percutaneous : pig – tail drainage.
  • 52. Pancreatic Abscess - Occurs as a complication of pseudo cyst if not drained. - Complicates about 4 % of cases. - The only reliable sign in CT is the presence of air bubbles within the cyst that arises mainly from gas forming organism or a fistula with the stomach, but unfortunately this is present only in 50 % of cases. - Diagnostic aspiration may differentiate it from a pseudo cyst if there is no air bubbles ( physical , bacteriology , cells ). - It was an indication for surgery in the past but now it could be drained percutaneously (pig tail).